Table 2.
Treatment | IC50 (mg/mL) |
Maximum Activity * (%) |
---|---|---|
Control | ND | 25.44 ± 1.39 e |
100 °C, 1 h | 13.94 ± 0.75 a | 45.14 ± 3.12 d |
100 °C, 2 h | 9.69 ± 0.56 b | 50.71 ± 1.25 cd |
100 °C, 3 h | 8.75 ± 0.75 b | 52.37 ± 1.39 c |
100 °C, 4 h | 8.38 ± 0.72 b | 55.11 ± 1.63 c |
121 °C, 1 h | 4.99 ± 0.33 c | 68.33 ± 2.38 b |
121 °C, 2 h | 1.90 ± 0.21 d | 87.03 ± 1.94 a |
121 °C, 3 h | 1.28 ± 0.16 d | 92.52 ± 4.11 a |
121 °C, 4 h | 1.05 ± 0.19 d | 92.69 ± 1.23 a |
* Maximum activity of all WSCGDs was determined at the same concentration of 10 mg/mL. ND: not detected. The letters a, b, c, d, e in the same column represent the statistical difference of means with p < 0.05 using Tukey-test. All data points in the table are mean and standard deviation. The anti-oxidant activity assay was conducted at 20 °C for 20 min.